Furthermore, pancancer survival analysis suggested that elevated TACC3 expression predicted poorer OS and RFS in multiple cancers, including pancreatic ductal adenocarcinoma and lung adenocarcinoma (Supplementary Fig. 1f, g). Here, TACC3 is linked to pancreatic ductal adenocarcinoma.